These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 10456955)

  • 41. Experimental Leishmania major infection in mice: role of IL-10.
    Chatelain R; Mauze S; Coffman RL
    Parasite Immunol; 1999 Apr; 21(4):211-8. PubMed ID: 10320618
    [TBL] [Abstract][Full Text] [Related]  

  • 42. KM(+), a lectin from Artocarpus integrifolia, induces IL-12 p40 production by macrophages and switches from type 2 to type 1 cell-mediated immunity against Leishmania major antigens, resulting in BALB/c mice resistance to infection.
    Panunto-Castelo A; Souza MA; Roque-Barreira MC; Silva JS
    Glycobiology; 2001 Dec; 11(12):1035-42. PubMed ID: 11805076
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Control of infection with Leishmania major in susceptible BALB/c mice lacking the common gamma-chain for FcR is associated with reduced production of IL-10 and TGF-beta by parasitized cells.
    Padigel UM; Farrell JP
    J Immunol; 2005 May; 174(10):6340-5. PubMed ID: 15879134
    [TBL] [Abstract][Full Text] [Related]  

  • 44. B-cell outgrowth and ligand-specific production of IL-10 correlate with Th2 dominance in certain parasitic diseases.
    Palanivel V; Posey C; Horauf AM; Solbach W; Piessens WF; Harn DA
    Exp Parasitol; 1996 Nov; 84(2):168-77. PubMed ID: 8932766
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Molecular cloning of a novel protein antigen of Leishmania major that elicits a potent immune response in experimental murine leishmaniasis.
    Webb JR; Kaufmann D; Campos-Neto A; Reed SG
    J Immunol; 1996 Dec; 157(11):5034-41. PubMed ID: 8943412
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Control of Leishmania major infection in BALB/c mice by inhibition of early lymphocyte entry into peripheral lymph nodes.
    Laskay T; Wittmann I; Diefenbach A; Röllinghoff M; Solbach W
    J Immunol; 1997 Feb; 158(3):1246-53. PubMed ID: 9013966
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Differential regulation of IL-9-expression after infection with Leishmania major in susceptible and resistant mice.
    Gessner A; Blum H; Röllinghoff M
    Immunobiology; 1993 Dec; 189(5):419-35. PubMed ID: 8125519
    [TBL] [Abstract][Full Text] [Related]  

  • 48. CC chemokine receptor 1 enhances susceptibility to Leishmania major during early phase of infection.
    Rodriguez-Sosa M; Rosas LE; Terrazas LI; Lu B; Gerard C; Satoskar AR
    Immunol Cell Biol; 2003 Apr; 81(2):114-20. PubMed ID: 12631234
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The induction of a protective response in Leishmania major-infected BALB/c mice with anti-CD40 mAb.
    Ferlin WG; von der Weid T; Cottrez F; Ferrick DA; Coffman RL; Howard MC
    Eur J Immunol; 1998 Feb; 28(2):525-31. PubMed ID: 9521062
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Expression of Th2 cytokines and the stable Th2 marker ST2L in the absence of IL-4 during Leishmania major infection.
    Kropf P; Schopf LR; Chung CL; Xu D; Liew FY; Sypek JP; Müller I
    Eur J Immunol; 1999 Nov; 29(11):3621-8. PubMed ID: 10556817
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Parasite dose determines the Th1/Th2 nature of the response to Leishmania major independently of infection route and strain of host or parasite.
    Menon JN; Bretscher PA
    Eur J Immunol; 1998 Dec; 28(12):4020-8. PubMed ID: 9862338
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Deletion of Interleukin-4 Receptor Alpha-Responsive Keratinocytes in BALB/c Mice Does Not Alter Susceptibility to Cutaneous Leishmaniasis.
    Govender M; Hurdayal R; Martinez-Salazar B; Gqada K; Pillay S; Gcanga L; Passelli K; Nieuwenhuizen NE; Tacchini-Cottier F; Guler R; Brombacher F
    Infect Immun; 2018 Dec; 86(12):. PubMed ID: 30275010
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The role of IL-12 in regulation of T helper cell subsets in vivo. Lessons from experimental cutaneous leishmaniasis.
    Scott P; Hondowicz B; Eaton A; Scharton-Kersten T
    Ann N Y Acad Sci; 1996 Oct; 795():250-6. PubMed ID: 8958936
    [No Abstract]   [Full Text] [Related]  

  • 54. Selective down-regulation of Th2 immune responses following treatment with antigen-coupled splenocytes.
    Soldera S; McSorley SJ; Glaichenhaus N
    Eur J Immunol; 1997 Apr; 27(4):848-54. PubMed ID: 9130634
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cathepsin L is crucial for a Th1-type immune response during Leishmania major infection.
    Onishi K; Li Y; Ishii K; Hisaeda H; Tang L; Duan X; Dainichi T; Maekawa Y; Katunuma N; Himeno K
    Microbes Infect; 2004 Apr; 6(5):468-74. PubMed ID: 15109961
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Regulatory interactions between CD45RBhigh and CD45RBlow CD4+ T cells are important for the balance between protective and pathogenic cell-mediated immunity.
    Powrie F; Correa-Oliveira R; Mauze S; Coffman RL
    J Exp Med; 1994 Feb; 179(2):589-600. PubMed ID: 7905019
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Immune response in a murine model of congenital toxoplasmosis: increased susceptibility of pregnant mice and transplacental passage of Toxoplasma gondii are type 2-dependent.
    Thouvenin M; Candolfi E; Villard O; Klein JP; Kien T
    Parassitologia; 1997 Dec; 39(4):279-83. PubMed ID: 9802080
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Blockade of CD86 ameliorates Leishmania major infection by down-regulating the Th2 response.
    Brown JA; Titus RG; Nabavi N; Glimcher LH
    J Infect Dis; 1996 Dec; 174(6):1303-8. PubMed ID: 8940222
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Leishmania major-infected murine langerhans cell-like dendritic cells from susceptible mice release IL-12 after infection and vaccinate against experimental cutaneous Leishmaniasis.
    von Stebut E; Belkaid Y; Nguyen BV; Cushing M; Sacks DL; Udey MC
    Eur J Immunol; 2000 Dec; 30(12):3498-506. PubMed ID: 11093169
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Leishmania susceptibility puzzle gets another twist.
    Marx J
    Science; 1996 Feb; 271(5251):912-3. PubMed ID: 8584928
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.